BFM
AZN icon

Boothbay Fund Management’s AstraZeneca AZN Stock Holding History

Boothbay Fund Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$741K Buy
3,909
+42
+1% +$7.9K 0.01% 1276
2026
Q1 		$763K Buy
+3,867
New +$746K 0.01% 1099
2025
Q4 		– Sell
-5,421
Closed -$832K – 1968
2025
Q3 		$832K Buy
+5,421
New +$820K 0.01% 911
2024
Q4 		– Sell
-28,392
Closed -$4.42M – 1497
2024
Q3 		$4.42M Buy
+28,392
New +$4.58M 0.1% 287
2024
Q2 		– Sell
-63,736
Closed -$9.59M – 1523
2024
Q1 		$8.64M Buy
63,736
+47,848
+301% +$6.34M 0.17% 97
2023
Q4 		$2.14M Buy
+15,888
New +$2.07M 0.05% 457
2023
Q3 		– Sell
-34,189
Closed -$4.67M – 1728
2023
Q2 		$4.89M Buy
34,189
+17,934
+110% +$2.64M 0.11% 214
2023
Q1 		$2.26M Buy
+16,255
New +$2.19M 0.05% 610
2022
Q4 		– Sell
-14,559
Closed -$1.6M – 2002
2022
Q3 		$1.6M Buy
+14,559
New +$1.85M 0.04% 667
2021
Q4 		– Sell
-32,578
Closed -$3.91M – 1863
2021
Q3 		$3.91M Sell
32,578
-30,945
-49% -$3.6M 0.11% 222
2021
Q2 		$7.61M Sell
63,523
-38,821
-38% -$4.26M 0.24% 81
2021
Q1 		$10.2M Buy
102,344
+52,809
+107% +$5.31M 0.38% 32
2020
Q4 		$4.95M Buy
49,535
+46,589
+1,581% +$4.93M 0.18% 99
2020
Q3 		$323K Sell
2,946
-7,665
-72% -$853K 0.02% 788
2020
Q2 		$1.12M Sell
10,611
-6,308
-37% -$651K 0.08% 352
2020
Q1 		$1.51M Sell
16,919
-19,535
-54% -$1.84M 0.13% 200
2019
Q4 		$3.63M Sell
36,454
-5,213
-13% -$491K 0.32% 69
2019
Q3 		$3.71M Buy
+41,667
New +$3.61M 0.34% 66

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boothbay Fund Management's AZN Position: Q2 2026 in Review

Boothbay Fund Management increased its AstraZeneca (AZN) stake by 1.1% in Q2 2026, buying an estimated $7.9K and bringing the position to 3,909 shares worth $741K. The position accounts for 0.01% of the portfolio, ranked #1276.

Boothbay Fund Management first reported a position in AZN in Q3 2019 and has held it in 18 quarters since. The position peaked at $10.2M in Q1 2021. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Boothbay Fund Management held 3,909 shares of AstraZeneca worth $741K as of Q2 2026.
  • Boothbay Fund Management bought 42 AstraZeneca shares in Q2 2026, an estimated $7.9K.
  • AstraZeneca made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1276 holding.
  • Boothbay Fund Management first reported a position in AstraZeneca in Q3 2019 and has held it in 18 quarters since.
  • Boothbay Fund Management's AstraZeneca position peaked at $10.2M in Q1 2021.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.